Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Frappaz

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Journal of Neuro-Oncology|April 14, 2007
French brain tumor data bank: methodology and first results on 10,000 casesLuc Bauchet, Valérie Rigau, Hélène Mathieu-Daudé, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2009
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European ConsortiumBirgit Geoerger, Bruce Morland, Anna Ndiaye, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2022
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysisMourad Hamimed, Pierre Leblond, Aurélie Dumont, et al.
The Lancet. Oncology|August 2, 2005
Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young childrenJacques Grill, Christian Sainte-Rose, Anne Jouvet, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyBirgit Geoerger, Julia Chisholm, Marie-Cecile Le Deley, et al.
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric OncologyVéronique Laithier, Jacques Grill, Marie-Cécile Le Deley, et al.
Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumoursHervé Rubie, Birgit Geoerger, Didier Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Journal of Neuro-Oncology|April 14, 2007
French brain tumor data bank: methodology and first results on 10,000 casesLuc Bauchet, Valérie Rigau, Hélène Mathieu-Daudé, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2009
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European ConsortiumBirgit Geoerger, Bruce Morland, Anna Ndiaye, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2022
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysisMourad Hamimed, Pierre Leblond, Aurélie Dumont, et al.
The Lancet. Oncology|August 2, 2005
Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young childrenJacques Grill, Christian Sainte-Rose, Anne Jouvet, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyBirgit Geoerger, Julia Chisholm, Marie-Cecile Le Deley, et al.
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric OncologyVéronique Laithier, Jacques Grill, Marie-Cécile Le Deley, et al.
Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumoursHervé Rubie, Birgit Geoerger, Didier Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Pageof 13